Antituberculosis drug resistance patterns in adults with tuberculous meningitis: results of haydarpasa-iv study
Articles > Article · 2015
Authors: Seniha SENBAYRAK, Nuri Ozkutuk, Hakan ERDEM, Isik Somuncu JOHANSEN, Rok CIVLJAK, AYŞE SEZA İNAL, Uner Kayabas, Ebru Kursun, NAZİF ELALDI, Branislava SAVIC, Soline SIMEON, Emel Yilmaz, Olga DULOVIC, Derya OZTURK-ENGIN, Nurgul CERAN, Botond LAKATOS, Oğuz Reşat SİPAHİ, Mustafa Sunbul, Mucahit Yemisen, Selma Alabay, Bojana BEOVIC, Aysegul Ulu-Kilic, Yasemin CAG, Melanie CATROUX, Asuman INAN, Gorana DRAGOVAC, Ozcan Deveci, Recep Tekin, Hanefi Cem GUL, Gonul SENGOZ, Katell ANDRE, Arjan HARXHI, Yves HANSMANN, Serkan Oncu, Sukran KOSE, Oral ONCUL, Emine Parlak, Alper Sener, Gulden Yilmaz, Umit SAVASCI, Haluk VAHABOGLU
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, Journal Indexed in SCI Expanded, International, 2015, vol 14
DOI: 10.1186/s12941-015-0107-z
Summary
Background: Tuberculous meningitis (TBM) caused by Mycobacterium tuberculosis resistant to antituberculosis drugs is an increasingly common clinical problem. This study aimed to evaluate drug resistance profiles of TBM isolates in adult patients in nine European countries involving 32 centers to provide insight into the empiric treatment of TBM.